x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

touchPODCAST

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare

science

All Episodes

16:09

Managing EoE: What options are emerging for patients?...

touchPODCAST ·

2022/05/24

touchMDT for touchIMMUNOLOGY Listen to leading experts engage in a case-based discussion on the management of EoE, covering both current practice and therapeutic options on the horizon. The multidisciplinary team Allergist/immunologist: Prof. Jonathan Spergel, USA Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands Dietitian: Dr Isabel Skypala, UK This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical educational grant from Regeneron

en

12:40

Symptoms of EoE: What is the burden for patients? -...

touchPODCAST ·

2022/05/24

touchMDT for touchIMMUNOLOGY Listen to a multidisciplinary team of experts as they explore the symptoms of EoE and their impact on patients in a case-based discussion of an adult newly presenting with food impaction. The multidisciplinary team Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands Allergist/immunologist: Prof. Jonathan Spergel, USA Dietitian: Dr Isabel Skypala, UK This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational grant from

en

11:41

Pathophysiology of EoE: What do we see in patients? -...

touchPODCAST ·

2022/05/24

touchMDT for touchIMMUNOLOGY Listen to leading experts discuss the environmental, genetic and immunological factors that contribute to the development of eosinophilic oesophagitis. The multidisciplinary team Allergist/immunologist: Prof. Jonathan Spergel, USA Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity

en

16:10

Managing EoE: What options are emerging for patients?...

touchPODCAST ·

2022/05/24

touchMDT for touchRESPIRATORY Listen to leading experts engage in a case-based discussion on the management of EoE, covering both current practice and therapeutic options on the horizon. The multidisciplinary team Allergist/immunologist: Prof. Jonathan Spergel, USA Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands Dietitian: Dr Isabel Skypala, UK This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc

en

12:40

Symptoms of EoE: What is the burden for patients?...

touchPODCAST ·

2022/05/24

touchMDT for touchRESPIRATORY Listen to a multidisciplinary team of experts as they explore the symptoms of EoE and their impact on patients in a case-based discussion of an adult newly presenting with food impaction. The multidisciplinary team Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands Allergist/immunologist: Prof. Jonathan Spergel, USA Dietitian: Dr Isabel Skypala, UK This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational grant from

en

11:43

Pathophysiology of EoE What do we see in patients -...

touchPODCAST ·

2022/05/24

touchMDT for touchRESPIRATORY Listen to leading experts discuss the environmental, genetic and immunological factors that contribute to the development of eosinophilic oesophagitis. The multidisciplinary team Allergist/immunologist: Prof. Jonathan Spergel, USA Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This medical education is

en

32:43

Experts discuss current and future best practice for...

touchPODCAST ·

2022/05/23

touchPANEL DISCUSSION for touchRESPIRATORY Listen to three leading experts discuss current and future best practice for the management of non-cystic fibrosis bronchiectasis, including risk factors for acute exacerbations, the management of chronic infection and available and emerging pharmacotherapeutic strategies. The experts Dr Charles Daley – National Jewish Health and University of Colorado, Denver, CO, USA; Icahn School of Medicine at Mount Sinai, New York, NY, USA Dr Anne O’Donnell –

en

32:44

Experts discuss current and future best practice for...

touchPODCAST ·

2022/05/23

touchPANEL DISCUSSION for touchINFECTIOUS DISEASES Listen to three leading experts discuss current and future best practice for the management of non-cystic fibrosis bronchiectasis, including risk factors for acute exacerbations, the management of chronic infection and available and emerging pharmacotherapeutic strategies. The experts Dr Charles Daley – National Jewish Health and University of Colorado, Denver, CO, USA; Icahn School of Medicine at Mount Sinai, New York, NY, USA Dr Anne O’Donnell –

en

13:11

MDT perspectives on minimizing TKI-associated...

touchPODCAST ·

2022/05/09

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team explore how to minimize toxicities while maximizing treatment benefit for patients with chronic myeloid leukaemia The multidisciplinary team Nurse specialist: Johan De Munter, Belgium Haematologist: Prof. Dr med. Andreas Hochhaus, Germany This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME. For further

en

14:03

MDT and patient advocate perspectives on what can be...

touchPODCAST ·

2022/05/09

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team, plus a patient advocate, consider real-life perspectives from patients with chronic myeloid leukaemia, and what HCPs can learn from them to improve outcomes The multidisciplinary team Haematologist: Prof. Dr med. Andreas Hochhaus, Germany Patient advocate: Jelena Čugurović, Serbia Nurse specialist: Johan De Munter, Belgium This touchPODCAST is for HCPs only. This activity is funded by an independent medical education

en

10:28

MDT perspectives on maximizing quality of life for...

touchPODCAST ·

2022/05/09

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss strategies to maximize the quality of life of patients with chronic myeloid leukaemia in the later-line setting The multidisciplinary team Pharmacist: Dr Bee Kim Tan, Malaysia Nurse specialist: Johan De Munter, Belgium This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME. For further information visit

en

13:59

MDT perspectives on later-line treatment options for CML

touchPODCAST ·

2022/05/09

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the later-line treatment options for chronic myeloid leukaemia, including T315I mutation-positive disease The multidisciplinary team Haematologist: Prof. Dr med. Andreas Hochhaus, Germany Pharmacist: Dr Bee Kim Tan, Malaysia This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME. For further information

en

12:06

Extending the benefit of PARP inhibitors through...

touchPODCAST ·

2022/05/05

touchMDT for touchONCOLOGY Listen to a medical oncologist, a urologist and an oncology pharmacist discuss extending the benefit of PARP inhibitors through combinations for the treatment of advanced prostate cancer. The multidisciplinary team Medical Oncologist: Dr Wassim Abida, USA Urologist: Professor Axel Merseburger, Germany Oncology Pharmacist: Dr Lisa Holle, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Pfizer. This activity is

en

12:15

PARP inhibitor combination clinical trials for...

touchPODCAST ·

2022/05/05

touchMDT for touchONCOLOGY Listen to a urologist and a medical oncologist discuss key clinical trials investigating PARP inhibitor combinations for the treatment of advanced prostate cancer. The multidisciplinary team Urologist: Professor Axel Merseburger, Germany Medical Oncologist: Dr Wassim Abida, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Pfizer. This activity is jointly provided by USF Health and touchIME. For

en

12:35

Rationale for PARP inhibitor combinations for...

touchPODCAST ·

2022/05/05

touchMDT for touchONCOLOGY Listen to an oncology pharmacist and a medical oncologist discuss the rationale for PARP inhibitors for the treatment of advanced prostate cancer. The multidisciplinary team Oncology Pharmacist: Dr Lisa Holle, USA Medical Oncologist: Dr Wassim Abida, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Pfizer. This activity is jointly provided by USF Health and touchIME. For further information visit

en

36:17

ENT experts discuss minimizing the clinical burden of...

touchPODCAST ·

2022/04/27

touchIN CONVERSATION for touchRESPIRATORY Listen to Professor Valerie Lund in conversation with Dr Sietze Reitsma. They respond to questions submitted by the HCP audience and provide their expert insights on the key considerations for minimizing the clinical burden of chronic rhinosinusitis with nasal polyposis. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is

en

36:18

ENT experts discuss minimizing the clinical burden of...

touchPODCAST ·

2022/04/27

touchIN CONVERSATION for touchIMMUNOLOGY Listen to Professor Valerie Lund in conversation with Dr Sietze Reitsma. They respond to questions submitted by the HCP audience and provide their expert insights on the key considerations for minimizing the clinical burden of chronic rhinosinusitis with nasal polyposis. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is

en

36:57

Considerations for the selection of disease-modifying...

touchPODCAST ·

2022/04/27

touchPANEL DISCUSSION for touchNEUROLOGY Listen as three experts in spinal muscular atrophy (SMA) discuss factors influencing treatment decision-making with approved SMA therapies using patient case studies. The experts Prof. Eugenio Mercuri – Policlinico Universitario Agostino Gemelli, Rome, Italy Prof. Nathalie Goemans – UZ Leuven, Leuven, Belgium Prof. Dr. med. Tim Hagenacker – Essen University Hospital, Essen, Germany This touchPODCAST is for HCPs only. This activity is funded by an

en

30:11

Improving patient outcomes in relapsing MS: Current...

touchPODCAST ·

2022/04/26

touchTALKS for touchNEUROLOGY Listen to a leading expert in multiple sclerosis (MS) discuss how disease-modifying therapies are currently used in clinical practice for the optimal management of relapsing MS. Prof. Patricia K Coyle highlights the importance of reducing the burden of the often ‘invisible’ symptoms of MS, such as fatigue, on overall patient quality of life, and reviews the latest, potentially practice-changing developments, which could further improve patient outcomes through shared

en

57:52

PARP inhibitors as first-line maintenance therapy in...

touchPODCAST ·

2022/04/20

touchCONGRESS for touchONCOLOGY Listen to Prof. Isabelle Ray-Coquard (France) cover key data presented at SGO 2022 on PARP inhibitors as first-line maintenance therapy in ovarian cancer, and their implications for clinical practice, including expert insights and interpretation from Dr Antonio González-Martín (Spain) and Dr Sandro Pignata (Italy). OVERVIEW Data review with Prof. Ray-Coquard (0:32) Expert interviews with Dr González-Martín, Dr Pignata and Prof. Ray-Coquard, answering the questions

en

532 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter